Putin announced that Russia approved a COVID-19 vaccine — and gave it to his daughter — despite serious concerns over its safety
- Russian President Vladimir Putin said on Tuesday that Russia had approved a COVID-19 vaccine, the world's first.
- "I know that it works quite effectively, forms strong immunity, and, I repeat, it has passed all the needed checks," Putin said on Tuesday.
- The move has raised concerns because it has not undergone phase 3 trials, which are considered essential to guarantee the safety of a vaccine.
Russian President Vladimir Putin says his government has approved the world's first
"I know that it works quite effectively, forms strong immunity, and, I repeat, it has passed all the needed checks," Putin said on Tuesday, according to Reuters.
He said one of his two daughters had been given the drug and was feeling well, according to the Associated Press, adding that he hoped the vaccine would begin mass production soon.
Russia has rolled out a COVID-19 vaccine at a fast pace even compared with other countries. Some officials have characterized the process as a race with other nations, particularly the US.
But scientists outside Russia have raised significant concerns about the so-called Gamaleya vaccine, named after the Gamaleya Institute in Moscow where it is being developed.
The concerns stem from the fact that the vaccine has not undergone phase 3 trials, which are considered essential to guarantee the safety of a vaccine.
There were widespread reports last month that scientists at the Gamaleya Institute had injected themselves with the prototype to speed up the development, and rushed through other tests.
Russia's Association of Clinical Research Organizations said the decision by scientists to inject themselves was a "crude violation of the very foundations of clinical research, Russian law, and universally accepted international regulations," according to the Associated Press.
Phase 3 trials, which usually involve thousands of participants, will instead begin after the vaccine has received regulatory approval, Reuters reported.
Russian government sources told Reuters last month that health workers would be offered the vaccine on a voluntary basis after it had received regulatory approval.
- Tax-friendly destinations: A guide to the world's lowest taxes countries
- Commercial LPG prices hiked by ₹209 across India
- The phenomenon behind tumultuous prices
- RBI extends deadline to exchange, deposit Rs 2,000 notes till Oct 7
- Explained: TCS on your child's overseas education and mitigating strategies